Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases.

The International journal of biological markers - 1 Jan 2000

Trevisiol C, Di Fabio F, Nascimbeni R, Peloso L, Salbe C, Ferruzzi E, Salerni B, Gion M

Abstract excerpt

While tissue KRAS2 mutations have been extensively investigated, the role of circulating mutant KRAS2 gene in patients with colorectal carcinoma remains obscure. The aim of the present study was to explore the prognostic significance of circulating KRAS2 gene mutational status in subjects undergoing primary treatment for colorectal cancer. Codon 12 KRAS2 mutations were examined in DNA samples extracted from the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-19-9 Antigen
Share to Carcinoembryonic Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Genes, ras

Share to Neoplasm Metastasis

Share to Proto-Oncogene Proteins

Share to Proto-Oncogene Proteins p21(ras)

Share to ras Proteins

Source

Identifiers

PMID: 17177160
DOI: 10.5301/jbm.2008.3336

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of circulating KRAS2 gene mutations in colorectal cancer with distant metastases.PMID 17177160Read ↗

A Clinical and Molecular Comparative Analysis of KRAS Exon 2 and KRAS Non-Exon 2 Mutated Colorectal CancerSemantic proximity Read ↗

Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy.Semantic proximity Read ↗

Comparison of KRAS mutation analysis of primary tumors and matched circulating cell-free DNA in plasmas of patients with colorectal cancerSemantic proximity Read ↗

KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.Semantic proximity Read ↗

Prognostic value of circulating mutant DNA in unresectable metastatic colorectal cancer.Semantic proximity Read ↗

KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.Semantic proximity Read ↗

A prospective study of circulating mutant <i>KRAS2</i> in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow upSemantic proximity Read ↗

Detection of mutated KRAS2 sequences as tumor markers in plasma/serum of patients with gastrointestinal cancer.Semantic proximity Read ↗

KRAS mutations in primary colorectal cancer tumors and related metastases: a potential role in prediction of lung metastasis.Semantic proximity Read ↗

Molecular detection of codon 12 K-RAS mutations in circulating DNA from serum of colorectal cancer patients.Semantic proximity Read ↗

Prognostic value of the combination of circulating tumor cells plus KRAS in patients with metastatic colorectal cancer treated with chemotherapy plus bevacizumab.Semantic proximity Read ↗

K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.